• Update on Secondary Cytoreduction in Recurrent Ovarian Cancer

    7 days ago - By Medscape

    Historically, immunotherapy has shown poor efficacy for recurrent ovarian malignancy, leaving few options for patients and their providers.
    MDedge
    Read more ...